# Perioperative mFOLFOX-6 in Locally Advanced Gastric Cancer

> **NCT02142322** · PHASE2 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 52 (actual)

## Conditions studied

- Advanced Gastric Cancer

## Interventions

- **DRUG:** MODIFIED FOLFOX6

## Key facts

- **NCT ID:** NCT02142322
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2025-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02142322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02142322, "Perioperative mFOLFOX-6 in Locally Advanced Gastric Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02142322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*